
Sun Pharma emerged as a strong consensus top pick among leading analysts, closing out the list with dual buy recommendations:
March 27, 2026
Source Information
NDTV
India
Lean right

Sun Pharma emerged as a strong consensus top pick among leading analysts, closing out the list with dual buy recommendations:
March 27, 2026